Min Tang

Min Tang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
XYXiaonan Yang
Xiaonan Yang
LKLing Kui
Ling Kui
MTMin Tang
Min Tang
DLDawei Li
Dawei Li
KWKunhua Wei
Kunhua Wei
YDYang Dong
Yang Dong
The development of new drugs is multidisciplinary and systematic work. High-throughput techniques based on “-omics” have driven the discovery of biomarkers in diseases and therapeutic targets of drugs. A transcriptome is the complete set of all RNAs transcribed by certain tissues or cells at a specific stage of development or physiological condition. Transcriptome research can demonstrate gene functions and structures from the whole level and reveal the molecular mechanism of specific biological processes in diseases. Currently, gene expression microarray and high-throughput RNA-sequencing have been widely used in biological, medical, clinical, and drug research. The former has been applied in drug screening and biomarker detection of drugs due to its high throughput, fast detection speed, simple analysis, and relatively low price. With the further development of detection technology and the improvement of analytical methods, the detection flux of RNA-seq is much higher but the price is lower, hence it has powerful advantages in detecting biomarkers and drug discovery. Compared with the traditional RNA-seq, scRNA-seq has higher accuracy and efficiency, especially the single-cell level of gene expression pattern analysis can provide more information for drug and biomarker discovery. Therefore, (sc)RNA-seq has broader application prospects, especially in the field of drug discovery. In this overview, we will review the application of these technologies in drug, especially in natural drug and biomarker discovery and development. Emerging applications of scRNA-seq and the third generation RNA-sequencing tools are also discussed.

1 August 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
QGQi Ge
Qi Ge
LCLiang Chen
Liang Chen
MTMin Tang
Min Tang
SZShu Zhang
Shu Zhang
LLLanlan Liu
Lanlan Liu
Keping ChenKeping Chen
Keping Chen

4 November 2015 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
MTMin Tang
Min Tang
JSJianqiang Sun
Jianqiang Sun
KSKentaro Shimizu
Kentaro Shimizu
KKKoji Kadota
Koji Kadota
RNA-seq is a powerful tool for measuring transcriptomes, especially for identifying differentially expressed genes or transcripts (DEGs) between sample groups. A number of methods have been developed for this task, and several evaluation studies have also been reported. However, those evaluations so far have been restricted to two-group comparisons. Accumulations of comparative studies for multi-group data are also desired. We compare 12 pipelines available in nine R packages for detecting differential expressions (DE) from multi-group RNA-seq count data, focusing on three-group data with or without replicates. We evaluate those pipelines on the basis of both simulation data and real count data. As a result, the pipelines in the TCC package performed comparably to or better than other pipelines under various simulation scenarios. TCC implements a multi-step normalization strategy (called DEGES) that internally uses functions provided by other representative packages (edgeR, DESeq2, and so on). We found considerably different numbers of identified DEGs (18.5 ~ 45.7 % of all genes) among the pipelines for the same real dataset but similar distributions of the classified expression patterns. We also found that DE results can roughly be estimated by the hierarchical dendrogram of sample clustering for the raw count data. We confirmed the DEGES-based pipelines implemented in TCC performed well in a three-group comparison as well as a two-group comparison. We recommend using the DEGES-based pipeline that internally uses edgeR (here called the EEE-E pipeline) for count data with replicates (especially for small sample sizes). For data without replicates, the DEGES-based pipeline with DESeq2 (called SSS-S) can be recommended.

14 August 2023 in Neural Regeneration Research
Verified
Journal Article
Open access
XLXiaoyan Liu
Xiaoyan Liu
YLYi Liu
Yi Liu
JLJunlin Liu
Junlin Liu
HZHantao Zhang
Hantao Zhang
CSChaofan Shan
Chaofan Shan
MTMin Tang
Min Tang
A growing body of evidence suggests that the gut microbiota contributes to the development of neurodegenerative diseases via the microbiota-gut-brain axis. As a contributing factor, microbiota dysbiosis always occurs in pathological changes of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. High-throughput sequencing technology has helped to reveal that the bidirectional communication between the central nervous system and the enteric nervous system is facilitated by the microbiota’s diverse microorganisms, and for both neuroimmune and neuroendocrine systems. Here, we summarize the bioinformatics analysis and wet-biology validation for the gut metagenomics in neurodegenerative diseases, with an emphasis on multi-omics studies and the gut virome. The pathogen-associated signaling biomarkers for identifying brain disorders and potential therapeutic targets are also elucidated. Finally, we discuss the role of diet, prebiotics, probiotics, postbiotics and exercise interventions in remodeling the microbiome and reducing the symptoms of neurodegenerative diseases.

1 September 2019 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
NWNiannian Wang
Niannian Wang
FZFeifei Zhu
Feifei Zhu
MSMingxiang Shen
Mingxiang Shen
LQLipeng Qiu
Lipeng Qiu
MTMin Tang
Min Tang
Keping ChenKeping Chen
Keping Chen

6 January 2025 in BMC Genomics
Verified
Journal Article
Open access
PDF file
GZGuowang Zhou
Guowang Zhou
MQMeiling Qin
Meiling Qin
XLXiuli Liu
Xiuli Liu
YQYonghui Qi
Yonghui Qi
XOXiaobin Ou
Xiaobin Ou
MTMin Tang
Min Tang
Glycyrrhiza glabra, which is widely used in medicine and therapy, is known as the ‘king of traditional Chinese medicine’. In this study, we successfully assembled and annotated the mitochondrial and chloroplast genomes of G. glabra via high-throughput sequencing technology, combining the advantages of short-read (Illumina) and long-read (Oxford Nanopore) sequencing. We revealed the ring structure of the mitochondrial genome, which spans 421,293 bp with 45.1% GC content and 56 annotated genes. Notably, we identified 514 repetitive sequences, including 123 Simple sequence repeats (SRs), 3 Tndem sequence repeats (TSRs), and 388 Dispersed sequence repeats (DSRs). We identified 79 out of the 388 DSRs as potentially involved in homologous recombination. We identified five forward repeats and four palindromic repeats that facilitate homologous recombination and induce alterations in the mitochondrial genome structure. We corroborated this finding via polymerase chain reaction (PCR). Furthermore, we identified chloroplast-derived sequence fragments within the mitochondrial genome, offering novel insights into the evolutionary history of plant mitochondrial genomes. We predicted 460 potential RNA editing sites, primarily involving cytosine-to-uracil transitions. This study reveals the complexity of repetitive sequence-mediated homologous recombination in the mitochondrial genome of G. glabra and provides new insights into its structure, function, and evolution. These findings have important implications for conservation biology, population genetics, and evolutionary studies, underscoring the role of repetitive sequences in genome dynamics and highlighting the need for further research on mitochondrial genome evolution and function in plants.